CPT® Code 95132

1. Indications

The procedure described by CPT® Code 95132 is indicated for patients who have been diagnosed with allergies to stinging insects, which may include various species such as bees, wasps, hornets, or yellow jackets. The following conditions warrant the use of allergen immunotherapy:

• Allergic Reactions to Stinging Insects Patients who experience significant allergic reactions, such as anaphylaxis or severe localized reactions, upon exposure to stinging insects.
• Positive Allergy Testing Individuals who have undergone allergy testing that confirms sensitivity to one or more stinging insect venoms.
• History of Severe Allergic Reactions Patients with a documented history of severe allergic reactions to stings, which may include symptoms such as difficulty breathing, swelling, or hives.

2. Procedure

The procedure for allergen immunotherapy as per CPT® Code 95132 involves several key steps that ensure the safe and effective administration of the treatment:

• Step 1: Allergy Testing Prior to initiating immunotherapy, patients must undergo allergy testing to identify specific stinging insect allergens. This testing is crucial for determining the appropriate allergenic extracts to be used in the immunotherapy regimen.
• Step 2: Development of Immunotherapy Schedule Based on the results of the allergy testing, a personalized immunotherapy schedule is created. This schedule outlines the build-up phase and the maintenance phase, detailing the frequency and dosage of allergenic extracts to be administered.
• Step 3: Build-Up Phase Administration During the build-up phase, patients receive injections of the allergenic extract(s) in gradually increasing doses. These injections are typically administered in the upper arm and occur one to three times per week over a period of 3 to 6 months. This phase is critical for developing tolerance to the allergens.
• Step 4: Transition to Maintenance Phase After the build-up phase, patients transition to the maintenance phase, which involves monthly injections of the allergenic extract(s). This phase can last for 3 to 5 years, providing ongoing exposure to the allergens to maintain desensitization.
• Step 5: Monitoring and Follow-Up Throughout the treatment process, patients are monitored for any adverse reactions or side effects. Follow-up appointments are essential to assess the effectiveness of the therapy and make any necessary adjustments to the treatment plan.

3. Post-Procedure

Post-procedure care following allergen immunotherapy involves several considerations to ensure patient safety and treatment efficacy. Patients are typically advised to remain in the office for a short period after receiving their injection to monitor for any immediate allergic reactions. It is important for patients to report any unusual symptoms, such as swelling, difficulty breathing, or hives, to their healthcare provider promptly. Additionally, patients may be instructed to avoid strenuous activities for a short time following the injection. Regular follow-up appointments are necessary to evaluate the patient's response to the therapy and to adjust the treatment plan as needed. Over the course of the maintenance phase, patients should continue to adhere to their scheduled injection appointments to maintain the benefits of desensitization.